Hanmi Pharm Co Ltd (128940) — Cash Flow-to-Debt Ratio
Hanmi Pharm Co Ltd (128940) has a Cash Flow-to-Debt Ratio of 0.06x as of September 2025, meaning its operating cash flow of ₩42.02 Billion could theoretically repay 0% of its total liabilities (₩694.79 Billion) in one year. Explore 128940 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Hanmi Pharm Co Ltd Cash Flow-to-Debt Ratio (2010–2024)
Historical debt coverage capacity for Hanmi Pharm Co Ltd across 15 annual periods. Also explore Hanmi Pharm Co Ltd assets under control for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Hanmi Pharm Co Ltd (2010–2024)
Year-by-year debt coverage analysis for Hanmi Pharm Co Ltd. For market capitalisation and broader financial context, see 128940 market cap.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.25x | ₩193.49 Billion | ₩780.09 Billion | ▼ -8.5% |
| 2023 | 0.27x | ₩216.54 Billion | ₩798.46 Billion | ▲ +53.0% |
| 2022 | 0.18x | ₩162.27 Billion | ₩915.36 Billion | ▼ -11.5% |
| 2021 | 0.20x | ₩201.92 Billion | ₩1.01 Trillion | ▲ +38.8% |
| 2020 | 0.14x | ₩151.53 Billion | ₩1.05 Trillion | ▲ +1165.4% |
| 2019 | 0.01x | ₩12.45 Billion | ₩1.09 Trillion | ▼ -60.4% |
| 2018 | 0.03x | ₩25.98 Billion | ₩901.95 Billion | ▲ +139.8% |
| 2017 | -0.07x | ₩-62.91 Billion | ₩868.51 Billion | ▼ -115.1% |
| 2016 | 0.48x | ₩412.97 Billion | ₩862.45 Billion | ▲ +360.3% |
| 2015 | 0.10x | ₩101.71 Billion | ₩977.78 Billion | ▲ +240.8% |
| 2014 | -0.07x | ₩-32.82 Billion | ₩444.09 Billion | ▼ -135.9% |
| 2013 | 0.21x | ₩85.99 Billion | ₩417.95 Billion | ▲ +38.6% |
| 2012 | 0.15x | ₩63.27 Billion | ₩426.25 Billion | ▼ -0.8% |
| 2011 | 0.15x | ₩61.30 Billion | ₩409.53 Billion | ▲ +233.7% |
| 2010 | 0.04x | ₩18.94 Billion | ₩422.34 Billion | — |